Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.
暂无分享,去创建一个
[1] D. Clarke,et al. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. , 2006, The Biochemical journal.
[2] A. Seelig. A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.
[3] D. Clarke,et al. Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site* , 2003, Journal of Biological Chemistry.
[4] D. Clarke,et al. Human P-glycoprotein is active when the two halves are clamped together in the closed conformation. , 2010, Biochemical and biophysical research communications.
[5] R. Dawson,et al. Structure of a bacterial multidrug ABC transporter , 2006, Nature.
[6] G. Chang,et al. Design and Synthesis of Selenazole‐Containing Peptides for Cocrystallization with P‐Glycoprotein , 2011, Chembiochem : a European journal of chemical biology.
[7] I. Pajeva,et al. Interactions of the Multidrug Resistance Modulators Tariquidar and Elacridar and their Analogues with P‐glycoprotein , 2013, ChemMedChem.
[8] Z. Sauna,et al. Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoprotein , 2001, The Journal of Biological Chemistry.
[9] R Hori,et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.
[10] D. Tieleman,et al. P‐glycoprotein models of the apo and ATP‐bound states based on homology with Sav1866 and MalK , 2007, FEBS letters.
[11] D. Clarke,et al. The Transmembrane Domains of the Human Multidrug Resistance P-glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell Surface* , 1999, The Journal of Biological Chemistry.
[12] Eszter Hazai,et al. Predicting P-Glycoprotein-Mediated Drug Transport Based On Support Vector Machine and Three-Dimensional Crystal Structure of P-glycoprotein , 2011, PloS one.
[13] D. Rees,et al. Structural Basis for Heavy Metal Detoxification by an Atm1-Type ABC Exporter , 2014, Science.
[14] D. Clarke,et al. Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.
[15] D. Clarke,et al. Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate* , 1997, The Journal of Biological Chemistry.
[16] P. Biggin,et al. Mass spectrometry reveals synergistic effects of nucleotides, lipids, and drugs binding to a multidrug resistance efflux pump , 2013, Proceedings of the National Academy of Sciences.
[17] D. Clarke,et al. Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. , 2006, The Biochemical journal.
[18] M. R. Lugo,et al. Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site. , 2005, Biochemistry.
[19] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[20] D. Baillie,et al. The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes , 2004, Genome Biology.
[21] D. Clarke,et al. The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis* , 2000, The Journal of Biological Chemistry.
[22] M. R. Lugo,et al. Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs. , 2005, Biochemistry.
[23] In-Wha Kim,et al. The power of the pump: mechanisms of action of P-glycoprotein (ABCB1). , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] Erik Evensen,et al. A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein. , 2002, Journal of medicinal chemistry.
[25] I. Pastan,et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.
[26] I. Pajeva,et al. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis). , 2002, Journal of medicinal chemistry.
[27] D. Clarke,et al. Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane* , 2000, The Journal of Biological Chemistry.
[28] S. Ambudkar,et al. Multidrug Resistance in Cancer: A Tale of ABC Drug Transporters , 2013 .
[29] R. Callaghan,et al. The translocation mechanism of P‐glycoprotein , 2006, FEBS letters.
[30] Michael Börsch,et al. Dynamic Ligand-induced Conformational Rearrangements in P-glycoprotein as Probed by Fluorescence Resonance Energy Transfer Spectroscopy* , 2011, The Journal of Biological Chemistry.
[31] D. Clarke,et al. Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein* , 2002, The Journal of Biological Chemistry.
[32] R. Callaghan,et al. The central cavity of ABCB1 undergoes alternating access during ATP hydrolysis , 2014, The FEBS journal.
[33] R. Plasterk,et al. A P‐glycoprotein protects Caenorhabditis elegans against natural toxins. , 1995 .
[34] V. Ling,et al. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. , 2001, European journal of biochemistry.
[35] Xuefeng Bruce Ling,et al. Significance Analysis and Multiple Pharmacophore Models for Differentiating P-Glycoprotein Substrates , 2007, J. Chem. Inf. Model..
[36] Stephan Kopp,et al. Multispecificity of Drug Transporters: Probing Inhibitor Selectivity for the Human Drug Efflux Transporters ABCB1 and ABCG2 , 2007, ChemMedChem.
[37] Stephen G Aller,et al. Refined structures of mouse P-glycoprotein , 2013, Protein science : a publication of the Protein Society.
[38] Gerhard F. Ecker,et al. In silico prediction of substrate properties for ABC-multidrug transporters , 2008 .
[39] Conserved Walker A cysteines 431 and 1074 in human P-glycoprotein are accessible to thiol-specific agents in the apo and ADP-vanadate trapped conformations. , 2013, Biochemistry.
[40] L. Greenberger,et al. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. , 1993, The Journal of biological chemistry.
[41] J. A. Nelson,et al. Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein. , 1994, The Journal of pharmacology and experimental therapeutics.
[42] Ricardo J. Ferreira,et al. Toward a Better Pharmacophore Description of P-Glycoprotein Modulators, Based on Macrocyclic Diterpenes from Euphorbia Species , 2011, J. Chem. Inf. Model..
[43] R. Dawson,et al. Structure and mechanism of ABC transporter proteins. , 2007, Current opinion in structural biology.
[44] Christoph Globisch,et al. Combined Pharmacophore Modeling, Docking, and 3D QSAR Studies of ABCB1 and ABCC1 Transporter Inhibitors , 2009, ChemMedChem.
[45] I. Pastan,et al. Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.
[46] D. Clarke,et al. Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil* , 2001, The Journal of Biological Chemistry.
[47] Stephan Kopp,et al. P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling Approach , 2005, Molecular Pharmacology.
[48] O. Jardetzky,et al. Simple Allosteric Model for Membrane Pumps , 1966, Nature.
[49] Geoffrey Chang,et al. Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. , 2010, Trends in biochemical sciences.
[50] Jue Chen,et al. Crystal structure of the multidrug transporter P-glycoprotein from C. elegans , 2012, Nature.
[51] V. Ling,et al. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. , 1997, European journal of biochemistry.
[52] Matthew P. Jacobson,et al. Predicting Binding to P-Glycoprotein by Flexible Receptor Docking , 2011, PLoS Comput. Biol..
[53] A. E. Senior,et al. The catalytic cycle of P‐glycoprotein , 1995, FEBS letters.
[54] A. di Pietro,et al. Understanding polyspecificity within the substrate‐binding cavity of the human multidrug resistance P‐glycoprotein , 2014, The FEBS journal.
[55] Michael M Gottesman,et al. Structure of a multidrug transporter , 2009, Nature Biotechnology.
[56] Yue Weng,et al. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.
[57] Zahida Parveen,et al. Molecular Dissection of Dual Pseudosymmetric Solute Translocation Pathways in Human P-Glycoprotein , 2011, Molecular Pharmacology.
[58] Z. Sauna,et al. Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[59] A. Barr,et al. Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states , 2013, Proceedings of the National Academy of Sciences.
[60] F. Sharom,et al. ABC efflux pump-based resistance to chemotherapy drugs. , 2009, Chemical reviews.
[61] H. Sitte,et al. Pore-Exposed Tyrosine Residues of P-Glycoprotein Are Important Hydrogen-Bonding Partners for Drugs , 2014, Molecular Pharmacology.
[62] P. Biggin,et al. Towards understanding promiscuity in multidrug efflux pumps. , 2014, Trends in biochemical sciences.
[63] S. Ambudkar,et al. Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein* , 1997, The Journal of Biological Chemistry.
[64] S. Ambudkar,et al. Pharmacophore Modeling of Nilotinib as an Inhibitor of ATP-Binding Cassette Drug Transporters and BCR-ABL Kinase Using a Three-Dimensional Quantitative Structure–Activity Relationship Approach , 2014, Molecular pharmaceutics.
[65] I. Pajeva,et al. Protein Contacts and Ligand Binding in the Inward‐Facing Model of Human P‐Glycoprotein , 2013, ChemMedChem.
[66] M. Ramachandra,et al. Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression System , 2000, The Journal of Membrane Biology.
[67] D. Clarke,et al. Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoprotein , 2003, The Journal of Biological Chemistry.
[68] R. Schimke,et al. Peptide transport by the multidrug resistance pump. , 1992, The Journal of biological chemistry.
[69] S. Durell,et al. Multiple Transport-Active Binding Sites Are Available for a Single Substrate on Human P-Glycoprotein (ABCB1) , 2013, PloS one.
[70] Hassane S. Mchaourab,et al. On the Origin of Large Flexibility of P-glycoprotein in the Inward-facing State* , 2013, The Journal of Biological Chemistry.
[71] S. Wilkens,et al. P-glycoprotein Retains Drug-stimulated ATPase Activity upon Covalent Linkage of the Two Nucleotide Binding Domains at Their C-terminal Ends* , 2011, The Journal of Biological Chemistry.
[72] E. Pardon,et al. Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain , 2013, Proceedings of the National Academy of Sciences.
[73] J. Drewe,et al. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. , 2000, Molecular pharmacology.
[74] Adam B. Shapiro,et al. Transport of LDS-751 from the cytoplasmic leaflet of the plasma membrane by the rhodamine-123-selective site of P-glycoprotein. , 1998, European journal of biochemistry.
[75] I. Pastan,et al. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[76] Geoffrey Chang,et al. Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.
[77] A. Schinkel,et al. P-Glycoprotein, a gatekeeper in the blood-brain barrier. , 1999, Advanced drug delivery reviews.
[78] F. Sharom. Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function , 2014, Front. Oncol..